Pan-cancer proteogenomics connects oncogenic drivers to functional states
Cell,
A multi-omics analysis-based resource across ten cancer types from more than 1,000 patients provides pan-cancer insights into…
A multi-omics analysis-based resource across ten cancer types from more than 1,000 patients provides pan-cancer insights into…
Les substances cancérigènes attaquent l’ADN de nos cellules. En perturbant leur bon fonctionnement, elles entraînent la…
cancer immunotherapy Larry H. Bernstein, MD, FCAP, Curator LPBI Research explains limits of cancer immunotherapy drugs…